May 1, 2021 “This is a historic moment in lupus with two new drug approvals for lupus nephritis just over a month,” enthused Kenneth M. Farber, LRA President and CEO. The LRA is excited to share that the U.S. Food and Drug Administration (FDA) has approved the use of voclosporin (Lupkynis™) as the first oral […] READ MORE
May 1, 2021 As an organization, the LRA is committed to promoting diversity, equity, and inclusion in all our work—not only because it is the right thing to do, but because lupus is a disease that disproportionately impacts people of color—particularly women. While it has been long established that 90 percent of those with lupus […] READ MORE
May 1, 2021 Ten new grant applications for promising lupus research have been recommended for funding under the Lupus Research Program within the Congressionally Directed Medical Research Programs at the Department of Defense! The LRA and advocates across the country helped establish this vital program which has been allocated $35 million in its first five […] READ MORE
May 1, 2021 The United States is in the midst of the biggest, fastest, most important vaccination campaign ever undertaken in our nation’s history. As of April 2021, more than 180 million doses have been given—with over 2.5 million doses being administered every day. Over the past year, the development of vaccines—and getting them in […] READ MORE
June 9, 2021 Enrico Costabile is sharing his story during Men’s Health Month to encourage others to avoid avoidance. “It’s better to ask and rule it out than to let it go untreated for too long. As men, we normally shrug symptoms off, but with lupus it can be a life-or-death situation like it nearly was for me. Get checked […] READ MORE
June 8, 2021 The annual European Congress of Rheumatology (EULAR 2021) brought much good news of potential new treatments for systemic lupus erythematosus (SLE). Following are highlights: Rituximab Plus Belimumab Taking belimumab after rituximab may help lupus according to data from the BEAT-LUPUS trial presented at the 2021 EULAR Virtual Congress by the trial lead investigator […] READ MORE
Research Is First to Pinpoint a Gut Organism to Lupus, Advancing Understanding of the Microbiome in Autoimmune Disease NEW YORK, NY. June 9. The Lupus Research Alliance (LRA) announced today that Martin Kriegel, MD, PhD, of the University of Münster is the 2021 Lupus Insight Prize Awardee for his cutting edge research in the understanding […] READ MORE
June 2, 2021 The Lupus Research Alliance’s strong financial health and commitment to accountability and transparency have earned it the coveted 4-star rating – the highest given – from Charity Navigator, America’s largest independent evaluator of U.S. charities. The Lupus Research Alliance has earned this top distinction every year since it was founded in 2016. […] READ MORE
June 1, 2021 As Lupus Awareness Month 2021 has come to a close, LRA President Ken Farber takes a look at the many ways we came together to Lift Up Lupus. Take pride in all the lupus community accomplished and hope in the tremendous progress underway. WATCH HERE As Ken touched on, here are some […] READ MORE
May 27, 2021 Funding innovative research year-round is the most meaningful way the Lupus Research Alliance Lifts Up Lupus with the promise of better treatments and one day a cure. This excellent article in EVERYDAY HEALTH reports on eight of the most important discoveries in lupus of the past year, virtually all of which got […] READ MORE
May 26, 2021 Memorial Day weekend is unofficially the beginning of summer, and this year, a particularly welcome opportunity to get outside with family or friends. Since several vaccines for COVID-19 were released, the U.S. Centers for Disease Control has started allowing travel and socializing again with specific guidelines. But as the beautiful weather calls […] READ MORE
May 14, 2021 The Lupus Research Alliance (LRA) is proud to share that one of our grantees Katherine A. Fitzgerald, PhD was elected into the National Academy of Sciences. Dr. Fitzgerald is recognized for her distinguished, original and continuing research in deciphering the molecular mechanisms of inflammatory processes that underpin a number of diseases including […] READ MORE
